210 related articles for article (PubMed ID: 28601984)
1. Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.
Engelmann I; Alidjinou EK; Bertin A; Bossu J; Villenet C; Figeac M; Sane F; Hober D
Cell Mol Life Sci; 2017 Oct; 74(20):3851-3861. PubMed ID: 28601984
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.
Alidjinou EK; Engelmann I; Bossu J; Villenet C; Figeac M; Romond MB; Sané F; Hober D
Virulence; 2017 Oct; 8(7):1229-1244. PubMed ID: 28112573
[TBL] [Abstract][Full Text] [Related]
3. Coxsackievirus B5 Infection Induces Dysregulation of microRNAs Predicted to Target Known Type 1 Diabetes Risk Genes in Human Pancreatic Islets.
Kim KW; Ho A; Alshabee-Akil A; Hardikar AA; Kay TW; Rawlinson WD; Craig ME
Diabetes; 2016 Apr; 65(4):996-1003. PubMed ID: 26558682
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.
Nekoua MP; Bertin A; Sane F; Alidjinou EK; Lobert D; Trauet J; Hober C; Engelmann I; Moutairou K; Yessoufou A; Hober D
Cell Mol Life Sci; 2020 Jan; 77(1):179-194. PubMed ID: 31172216
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?
El-Senousy WM; Abdel-Moneim A; Abdel-Latif M; El-Hefnawy MH; Khalil RG
Food Environ Virol; 2018 Mar; 10(1):89-98. PubMed ID: 29022248
[TBL] [Abstract][Full Text] [Related]
6. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
Jaïdane H; Hober D
Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B4 Exposure Results in Variable Pattern Recognition Response in the Kidneys of Female Non-Obese Diabetic Mice Before Establishment of Diabetes.
Walter DL; Benner SE; Oaks RJ; Thuma JR; Malgor R; Schwartz FL; Coschigano KT; McCall KD
Viral Immunol; 2020 Sep; 33(7):494-506. PubMed ID: 32352894
[TBL] [Abstract][Full Text] [Related]
8. Upregulated microRNA-214 enhances cardiac injury by targeting ITCH during coxsackievirus infection.
Chen ZG; Liu H; Zhang JB; Zhang SL; Zhao LH; Liang WQ
Mol Med Rep; 2015 Jul; 12(1):1258-64. PubMed ID: 25815880
[TBL] [Abstract][Full Text] [Related]
9. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.
Richer MJ; Horwitz MS
Autoimmun Rev; 2009 Jun; 8(7):611-5. PubMed ID: 19393207
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells.
Bertin A; Sane F; Gmyr V; Lobert D; Dechaumes A; Kerr-Conte J; Pattou F; Hober D
Viruses; 2019 Jul; 11(7):. PubMed ID: 31269669
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction.
Berger MM; See DM; Aymard M; Lina B
Clin Diagn Virol; 1998 Apr; 9(2-3):141-3. PubMed ID: 9645996
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of putative novel microRNA expression profiles induced by enterovirus 71 and coxsackievirus A16 infections in human umbilical vein endothelial cells using high-throughput sequencing.
Song J; Hu Y; Zheng H; Guo L; Huang X; Jiang X; Li W; Li J; Yang Z; Dong S; Liu L
Infect Genet Evol; 2019 Sep; 73():401-410. PubMed ID: 31176031
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies.
Frisk G; Tuvemo T
J Med Virol; 2004 Jul; 73(3):450-9. PubMed ID: 15170642
[TBL] [Abstract][Full Text] [Related]
15. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.
Jaïdane H; Sauter P; Sane F; Goffard A; Gharbi J; Hober D
Rev Med Virol; 2010 Sep; 20(5):265-80. PubMed ID: 20629044
[TBL] [Abstract][Full Text] [Related]
16. [Coxsackievirus B infection and pathogenesis of type 1 diabetes].
Nekoua MP; Mercier A; Vergez I; Morvan C; Mbani CJ; Sane F; Lobert D; Engelmann I; Romond MB; Alidjinou EK; Hober D
Virologie (Montrouge); 2022 DéCembre 01; 26(6):415-430. PubMed ID: 36565260
[TBL] [Abstract][Full Text] [Related]
17. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
18. Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.
Elmastour F; Jaïdane H; Benkahla M; Aguech-Oueslati L; Sane F; Halouani A; Engelmann I; Bertin A; Mokni M; Gharbi J; Aouni M; Alidjinou EK; Hober D
Virulence; 2017 Aug; 8(6):908-923. PubMed ID: 27792461
[TBL] [Abstract][Full Text] [Related]
19. Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study.
Nekoua MP; Yessoufou A; Alidjinou EK; Badia-Boungou F; Moutairou K; Sane F; Hober D
Acta Diabetol; 2018 Aug; 55(8):827-834. PubMed ID: 29774468
[TBL] [Abstract][Full Text] [Related]
20. The CVB and etiology of type 1 diabetes.
Drescher KM; Tracy SM
Curr Top Microbiol Immunol; 2008; 323():259-74. PubMed ID: 18357774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
